This group supports the Environmental Protection Agency’s (EPA) efforts to protect public health and the environment through the Residual Risk and Technology Review (RTR) process and recognizes the
need to develop stringent emissions standards to mitigate any potential hazards posed by Ethylene Oxide (EtO) emissions. However, they are also cautious of the impact these changes may have on the availability and timely delivery of biotherapeutics to patients who rely on them. Biotherapeutics, including vaccines, therapeutics, and other life-saving medications, play a crucial role in improving patient health outcomes and saving lives. For the biopharmaceutical industry, EtO sterilization is a critical process used to ensure product safety and efficacy. The EtO Response team raised several concerns regarding the potential impact of the proposed rule changes on the biotherapeutics market. This document discusses the concerns.
Sustainability
Viewing related articles
BioPhorum response to the Annex XV report on the proposal for universal PFAS restrictions
May 2023 | Deliverable, Deliverables Report, Drug Substance, Feedback to agency, Fill Finish, POI - Supply Partner, Supply Partner, Sustainability
The BioPhorum response to the Annex XV Report on the proposal for universal PFAS restrictions. It is considered by the BioPhorum collaboration that unless ECHA provide the biopharmaceutical manufacturing industry with appropriate exemptions or derogations to find, test and validate alternatives and execute a transition out of these materials (where alternatives are available), there will be a real threat to the global availability of critical vaccines and biotherapeutics.
BioPhorum environmental sustainability roadmap 2022
Dec 2022 | Cell & Gene Therapy, Deliverable, Deliverables Report, Development Group, Drug Substance, Fill Finish, Information Technology, MediPhorum, POI - Sustainability, Publication, Regulatory, Supply Chain to Patient, Supply Partner, Sustainability, Technology Strategy
Climate change and global warming resulting from greenhouse gas emissions are widely recognized as the biggest threats to global health. The healthcare sector is responsible for 4–5% of global emissions, more than 70% of which are driven by supply chains.
Sustainability initiatives
May 2022 | Deliverable, Deliverables Report, Publication, Sustainability
A BioPhorum member only tool providing a useful collection of standards, reporting mechanisms and standards bodies within the sustainability arena
Product stewardship survey
Mar 2022 | Benchmarking, Deliverable, Deliverables Report, Sustainability
A BioPhorum member survey looking at the importance of product stewardship that will help form the program for BioPhorum Sustainability. The results of this survey are only available to members of BioPhorum Sustainability.